ContributorsPublishersAdvertisers

First-in-Human Trial with CAR Macrophages Shows the Cell Therapy May Be Safe, Feasible for Solid Tumors

Newswise
 2022-01-11

Cover picture for the articleNewswise — PHILADELPHIA — Preliminary findings from Penn Medicine in an ongoing first-in-human clinical trial examining the safety, tolerability and feasibility of chimeric antigen receptor macrophage (CAR-M) has helped to establish the viability of this innovative immunotherapy, which advances the trailblazing scientific discovery of CAR T cell therapy—also pioneered at Penn—for...

www.newswise.com

Comments / 0

Comments / 0